Omnicell, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OMCL research report →
Companywww.omnicell.com
Omnicell, Inc. , together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.
- CEO
- Randall A. Lipps
- IPO
- 2001
- Employees
- 3,620
- HQ
- Mountain View, CA, US
Price Chart
Valuation
- Market Cap
- $2.03B
- P/E
- 99.19
- P/S
- 1.66
- P/B
- 1.61
- EV/EBITDA
- 16.48
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 43.50%
- Op Margin
- 2.83%
- Net Margin
- 1.67%
- ROE
- 1.64%
- ROIC
- 1.22%
Growth & Income
- Revenue
- $1.18B · 6.53%
- Net Income
- $2.05M · -83.62%
- EPS
- $0.04 · -83.48%
- Op Income
- $11.66M
- FCF YoY
- -42.56%
Performance & Tape
- 52W High
- $55.00
- 52W Low
- $26.85
- 50D MA
- $37.95
- 200D MA
- $37.71
- Beta
- 0.96
- Avg Volume
- 586.68K
Get TickerSpark's AI analysis on OMCL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Njoku Nnamdi | other | 3,660 |
| May 18, 26 | Njoku Nnamdi | sell | 3,090 |
| May 15, 26 | NUTT BRIAN H. | other | 226 |
| May 15, 26 | Manley Corey J | other | 4,041 |
| May 18, 26 | Manley Corey J | sell | 5,025 |
| May 15, 26 | LIPPS RANDALL A | other | 12,347 |
| Apr 1, 26 | Njoku Nnamdi | other | 46,296 |
| Apr 1, 26 | Manley Corey J | other | 25,132 |
| Apr 1, 26 | LIPPS RANDALL A | other | 90,939 |
| Apr 1, 26 | Radford Harlan Baird | other | 37,037 |
Our OMCL Coverage
We haven't published any research on OMCL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate OMCL Report →